Health
Viral ‘molecular scissor’ is next COVID-19 drug target: Coronavirus uses enzymatic cutter for virus production and to disable essential immune proteins – Benzinga
Inhibiting the “scissor” activity of an enzyme of SARS-CoV-2, the coronavirus that causes COVID-19, could be a basis for treatment of the …
Inhibiting the “scissor” activity of an enzyme of SARS-CoV-2, the coronavirus that causes COVID-19, could be a basis for treatment of the infection, researchers at The University of Texas Health Science Center at San Antonio and the Wroclaw University of Science and Technology discovered.
SAN ANTONIO (PRWEB) October 18, 2020
American and Polish scientists, reporting Oct. 16 in the journal Science Advances, laid out a novel rationale for COVID-19 drug design blocking a molecular “scissor” tha…
-
General14 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News23 hours agoRainbow Beach surfer’s untold 7/7 story
-
Noosa News14 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Business20 hours agoInvested $10,000 in Westpac shares 2 years ago? Guess how much you’ve already banked!